Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells
2004

How Oestrogen Affects Resveratrol in Breast Cancer Cells

publication 10 minutes Evidence: moderate

Author Information

Author(s): Zhang S, Cao H, Davis F B, Tang H-Y, Davis P J, Lin H-Y

Primary Institution: The Ordway Research Institute

Hypothesis

Does oestrogen inhibit the apoptosis induced by resveratrol in breast cancer cells?

Conclusion

Oestrogen inhibits resveratrol-induced apoptosis in breast cancer cells by interfering with the post-translational modifications of p53.

Supporting Evidence

  • Resveratrol induced apoptosis in MCF-7 cells, but this effect was blocked by oestrogen.
  • Oestrogen inhibited the phosphorylation and acetylation of p53, which are necessary for its activity.
  • Using an oestrogen receptor inhibitor, the study showed that the effects of oestrogen on p53 were receptor-mediated.
  • Resveratrol's ability to activate MAPK was enhanced by oestrogen, but this did not lead to increased apoptosis.

Takeaway

This study found that oestrogen stops a substance called resveratrol from making cancer cells die. It does this by changing a protein called p53 that helps control cell death.

Methodology

The study used MCF-7 breast cancer cells to examine the effects of resveratrol and oestrogen on p53 modifications and apoptosis through various assays.

Limitations

The study primarily focused on a single cell line, which may not represent all breast cancer types.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1038/sj.bjc.6601902

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication